Sartorius AG (0NIQ) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

and a warm welcome from my side. I'm joined today by our CEO, Michael Große, by Florian Funk, our CFO, by René Faber, Head of our Bioprocessing Division and CEO of the Terrestrial Biotech, and by Alexandra Gatzmeier, Head of our Products and Services Division. As always, we will start with prepared remarks followed by the Q&A session. As the call is scheduled to one hour, please limit your question to one so that as many participants as possible can take part. Please note that management comments during this call will include forward-looking statements that involve risks and uncertainty for discussion of risk factors. I encourage you to review the safe harbor statement contained in today's press release and presentation. With that, I'm pleased to hand over to Michael Postel, CEO of Sartorius. Michael, please go ahead. Thank you very much, Petra, and a warm welcome also from my side. And thank you all for joining us today for our preliminary full year 2025 results. Before we begin, I would like to sincerely thank all of our colleagues across Sartorius for their commitment and dedication over the past year. Their passion, professionalism, and strong focus on execution are clearly reflected in our results we are presenting today. I would also like to personally thank everyone who has made it such a smooth and rewarding experience for me to step into my role as a CEO, and particular thanks as well to my colleagues here, Alexander, Renee, and Dorian from the executive team, It's been a really great journey up to now, fantastic work on the strategy, and great things to come. And I don't want to miss out as well on saying thank you to the team here from investor relations, communications, and finance, because I think the workload over the last couple of weeks and days has b...